COYA THERAPEUTICS INC (COYA) Stock Balance Sheet
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 31.06M | 32.63M | 5.93M | 4.34M | 8.72M | |||
| Receivables | N/A | 7.50M | N/A | 0.00 | 0.00 | |||
| Other Current Assets | 4.45M | 1.07M | 1.25M | 240.00K | 30.00K | |||
| Total Current Assets | 35.51M | 41.20M | 7.18M | 4.58M | 8.75M | |||
| Non-Current Assets | ||||||||
| PPE Net | 45.40K | 66.00K | 90.00K | 120.00K | 0.00 | |||
| Other Non-Current Assets | N/A | 0.00 | 1.12M | 90.00K | 0.00 | |||
| Total Non-Current Assets | 45.40K | 66.00K | 1.22M | 210.00K | 0.00 | |||
| TOTAL ASSETS | 35.55M | 41.26M | 8.40M | 4.79M | 8.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.41M | 2.25M | 2.01M | 290.00K | 0.00 | |||
| Accounts Payable | 336.70K | 1.16M | 1.82M | 860.00K | 450.00K | |||
| Other Current Liabilities | 573.10K | 1.65M | N/A | N/A | N/A | |||
| Total Current Liabilities | 2.32M | 5.05M | 3.82M | 1.15M | 450.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 12.97M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.22M | 574.70K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.22M | 574.70K | 12.97M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.54M | 5.63M | 16.79M | 1.15M | 450.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -37.82M | -25.86M | -17.87M | -5.62M | -730.00K | |||
| Additional Paid In Capital | 69.83M | 61.50M | 680.00K | 470.00K | 240.00K | |||
| Common Shares | 1.50K | 1.40K | 8.79M | 8.79M | 8.79M | |||
| Other Shareholders' Equity | 0.00 | -11.30K | N/A | N/A | N/A | |||
| Shares Outstanding | 15.22M | 14.41M | 9.95M | 9.65M | 9.65M | |||
| Tangible Book Value per Share | 2.10 | 2.47 | -1.73 | -0.53 | -0.05 | |||
| Total Shareholders' Equity | 32.01M | 35.64M | -8.39M | 3.64M | 8.30M | |||
| TOTAL LIABILITIES AND EQUITY | 35.55M | 41.26M | 8.40M | 4.79M | 8.75M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | -1.55 | N/A | N/A | |||
| Current Ratio | 15.31 | 8.15 | 1.88 | 3.98 | 19.44 | |||
| Return On Assets (ROA) | -30.09% | -19.36% | -145.71% | -102.09% | -8.34% | |||
| Return On Equity (ROE) | -33.42% | -22.42% | N/A | -134.34% | -8.80% | |||
All data in USD , ROIC based on taxRate of 0.21